BIO-RAD LABORATORIES, INC. — Director's Dealing 2021

Nov 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-11-11

Reporting Person: TUMOLO ANNETTE (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-11	Bio-Rad A Common Stock	M	613	$333.34	Acquired	5206.3476	Direct
2021-11-11	Bio-Rad A Common Stock	M	500	$333.34	Acquired	5706.3476	Direct
2021-11-11	Bio-Rad A Common Stock	M	433	$524.30	Acquired	6139.3476	Direct
2021-11-11	Bio-Rad A Common Stock	S	433	$748.08	Disposed	5706.3476	Direct
2021-11-11	Bio-Rad A Common Stock	S	613	$748.84	Disposed	5093.3476	Direct
2021-11-11	Bio-Rad A Common Stock	S	500	$750.00	Disposed	4593.3476	Direct
2021-11-12	Bio-Rad A Common Stock	M	600	$159.32	Acquired	5193.3476	Direct
2021-11-12	Bio-Rad A Common Stock	M	2400	$215.98	Acquired	7593.3476	Direct
2021-11-12	Bio-Rad A Common Stock	M	1800	$326.15	Acquired	9393.3476	Direct
2021-11-12	Bio-Rad A Common Stock	S	4800	$750.05	Disposed	4593.3476	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-11	Non-Qualified Stock Option (right to buy)	$524.30	M	433	Disposed	2030-09-02	Bio-Rad A Common Stock (433)	Direct
2021-11-11	Non-Qualified Stock Option (right to buy)	$333.34	M	1113	Disposed	2029-09-03	Bio-Rad A Common Stock (1113)	Direct
2021-11-12	Non-Qualified Stock Option (right to buy)	$326.15	M	1800	Disposed	2028-09-04	Bio-Rad A Common Stock (1800)	Direct
2021-11-12	Non-Qualified Stock Option (right to buy)	$215.98	M	2400	Disposed	2027-09-05	Bio-Rad A Common Stock (2400)	Direct
2021-11-12	Non-Qualified Stock Option (right to buy)	$159.32	M	600	Disposed	2026-09-07	Bio-Rad A Common Stock (600)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $750.00 to $750.61, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The option, representing a right to purchase a total of 1,733 shares, became exercisable in four equal annual installments beginning on September 2, 2021, which was the first anniversary of the date on which the option was granted.

F3: The option, representing a right to purchase a total of 2,784 shares, became exercisable in five equal annual installments beginning on September 3, 2020, which was the first anniversary of the date on which the option was granted.

F4: The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 4, 2019, which was the first anniversary of the date on which the option was granted.

F5: The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted.

F6: The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.